Time trends in breast cancer incidence and mortality in a mid-sized northeastern Brazilian city

<p>Abstract</p> <p>Background</p> <p>Breast cancer incidence within an area is usually proportional to the area’s income level. High-income areas have shown the highest incidence rates and since 2003, negative trends. As for mortality, rates are often higher in low-inco...

Full description

Bibliographic Details
Main Authors: Lima Carlos, Rangel Margareth Rose, Macedo-Lima Matheus, da Silva Angela
Format: Article
Language:English
Published: BMC 2012-10-01
Series:BMC Public Health
Subjects:
Online Access:http://www.biomedcentral.com/1471-2458/12/883
Description
Summary:<p>Abstract</p> <p>Background</p> <p>Breast cancer incidence within an area is usually proportional to the area’s income level. High-income areas have shown the highest incidence rates and since 2003, negative trends. As for mortality, rates are often higher in low-income regions. The purpose of this study was to analyze trends in incidence and mortality in a capital city of a northeastern Brazilian state with an intermediate human development index.</p> <p>Methods</p> <p>Incidence data from the Population-Based Cancer Registry of Aracaju and mortality data from the Official State Database for the period 1996–2006 were used. Incidence and mortality crude and age-standardized rates were calculated. Time trends were obtained using the Joinpoint Regression Model.</p> <p>Results</p> <p>For the period studied, invasive breast cancer age-standardized incidence rates increased annually with an annual percentage change (APC) of 2.9 (95% CI: 1.2-4.6). Significant increasing trends were observed in groups aged 45–54 years (APC: 3.9, 95% CI: 1.4 to 6.6), and 55–64 years (APC: 5.6, 95% CI: 1.8 to 9.6). Age-standardized mortality rates did not show an increasing trend (APC: 3.0, (95% CI: -2.8 to9.1), except for the group aged 55–64 years (APC: 11.3, 95% CI: 1.1 to 22.4).</p> <p>Conclusions</p> <p>In the study community, breast cancer showed increasing incidence among women in the peri- and postmenopausal periods. However, mortality did not present increasing overall trends, except for among the group aged 55–64 years. For better outcomes, screening policies should focus on the peri- and postmenopausal periods of women’s lives to diagnose disease.</p>
ISSN:1471-2458